US2013295201A1PendingUtilityA1
Methods for Inhibiting Sensory Nerves by Topically Administering Strontium-Containing Compositions to Keratinized Skin
Est. expiryDec 21, 2014(expired)· nominal 20-yr term from priority
A61P 29/00A61Q 17/00A61Q 15/00A61Q 5/04A61K 31/28A61Q 5/00A61K 33/14A61K 8/19A61K 33/00A61K 45/06A61K 31/19A61K 2800/75A61P 17/04A61Q 1/02A61Q 9/02A61Q 1/06A61Q 19/00A61K 8/20A61Q 19/10A61Q 5/12A61K 8/365A61P 17/00A61K 33/24
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle, and methods of using these formulations to inhibit skin irritation in keratinized skin, are disclosed.
Claims
exact text as granted — not AI-modified1 .- 12 . (canceled)
13 . A method for relieving pain comprising topically applying a compound to keratinized skin comprising a strontium cation, a counterion, and a delivery vehicle.
14 . The method of claim 13 , wherein the delivery vehicle is selected from the group consisting of: water, organic solvents, lipid-based materials, protein-based materials, silicone-based materials, hydrocarbon-based materials, surfactants, soaps, sustained-release vehicles, stabilizing and suspending agents, emulsifying agents and mixtures of the foregoing.
15 . The method of claim 13 , wherein the couterion is selected from the group consisting of: fluoride, chloride, bromide, idodine, carbonate, bicarbonate, hydroxide, oxide, peroxide, nitrite, sulfide, bisulfate, persulfate, glycerophosphate, hypophosphate, borate, titanate, carboxylic acid, alkoxylate, citrate, oxalate, acetate, fluconate, lactate, tartrate, maleate, benzoate, propionate, salicylate, ascorbate, formate, succinate, folinate, aspartate, phthalate, oleate, palmitate, stearate, lauryl sulfate, lanolate, myrisatte, behenate, casinate, cyclamate, pantothenate, EDTA, saccharin, thioglycolate, alurate, methylparaben, proylparaben, ricinoleate, and sorbate.
16 . The method of claim 13 , wherein the compound further comprises a solvent.
17 . The method of claim 13 , wherein the compound further comprises a skin penetration enhancer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.